Antonio Uccelli
#159,445
Most Influential Person Now
Italian neurologist and researcher
Antonio Uccelli's AcademicInfluence.com Rankings
Antonio Uccellimedical Degrees
Medical
#3179
World Rank
#3634
Historical Rank
Radiology
#61
World Rank
#72
Historical Rank
Neurology
#293
World Rank
#375
Historical Rank
Antonio Uccellibiology Degrees
Biology
#12504
World Rank
#15983
Historical Rank
Neuroscience
#2104
World Rank
#2162
Historical Rank
Download Badge
Medical Biology
Antonio Uccelli's Degrees
- Bachelors Neuroscience University of Milan
- PhD Neuroscience University of Florence
Why Is Antonio Uccelli Influential?
(Suggest an Edit or Addition)Antonio Uccelli's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Mesenchymal stem cells in health and disease (2008) (3126)
- Human mesenchymal stem cells modulate B-cell functions. (2006) (1681)
- Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. (2005) (1423)
- C-C chemokine receptor 6–regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE (2009) (1099)
- Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study (2018) (559)
- Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis (2007) (467)
- Mesenchymal stem cells: a new strategy for immunosuppression? (2007) (444)
- Immunoregulatory function of mesenchymal stem cells (2006) (439)
- Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. (2004) (354)
- Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. (2006) (310)
- Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases (2011) (265)
- Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells (2011) (262)
- Human Mesenchymal Stem Cells Promote Survival of T Cells in a Quiescent State (2007) (259)
- Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study (2015) (255)
- The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group (2010) (218)
- Neuroprotective features of mesenchymal stem cells. (2011) (216)
- Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor. (1995) (181)
- Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005 (2007) (176)
- Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo (2009) (174)
- Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS (2003) (172)
- Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application (2008) (172)
- T‐cell trafficking in the central nervous system (2012) (160)
- Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus. (2010) (159)
- Reciprocal Interactions Between Human Mesenchymal Stem Cells and γδ T Cells Or Invariant Natural Killer T Cells (2009) (158)
- The immunomodulatory function of mesenchymal stem cells: mode of action and pathways (2015) (155)
- Catastrophic NAD+ Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE (2009) (153)
- Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS (2015) (150)
- COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role? (2020) (141)
- Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies (2021) (136)
- Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies (2021) (136)
- Intravenous Mesenchymal Stem Cells Improve Survival and Motor Function in Experimental Amyotrophic Lateral Sclerosis (2012) (136)
- Why should mesenchymal stem cells (MSCs) cure autoimmune diseases? (2010) (134)
- Cell-based therapeutic strategies for multiple sclerosis (2017) (128)
- Mesenchymal Stem Cells Shape Microglia Effector Functions Through the Release of CX3CL1 (2012) (127)
- Sea level rise, hydrologic runoff, and the flooding of Venice (2008) (124)
- Vaccination with amyloid-beta peptide induces autoimmune encephalomyelitis in C57/BL6 mice. (2003) (119)
- Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience (2012) (117)
- Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks (2009) (116)
- α-Lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis (2004) (115)
- Myelin/Oligodendrocyte Glycoprotein-Induced Autoimmune Encephalomyelitis in Common Marmosets: The Encephalitogenic T Cell Epitope pMOG24–36 Is Presented by a Monomorphic MHC Class II Molecule1 (2000) (107)
- Low-Dose Gabapentin Combined with either Lamotrigine or Carbamazepine Can Be Useful Therapies for Trigeminal Neuralgia in Multiple Sclerosis (2000) (106)
- Effect of copolymer-1 on serial gadolinium-enhanced MRI in relapsing remitting multiple sclerosis (1998) (100)
- Isolated cognitive relapses in multiple sclerosis (2014) (97)
- Local-clonal expansion of infiltrating T lymphocytes in chronic encephalitis of Rasmussen. (1997) (93)
- Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure (2019) (93)
- Surrogate endpoints for EDSS worsening in multiple sclerosis (2010) (84)
- Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial (2019) (83)
- Unveiling the enigma of the CNS as a B-cell fostering environment. (2005) (82)
- The therapeutic effect of mesenchymal stem cell transplantation in experimental autoimmune encephalomyelitis is mediated by peripheral and central mechanisms (2012) (78)
- Demyelination and axonal damage in a non-human primate model of multiple sclerosis (2001) (77)
- Fingolimod Modulates Peripheral Effector and Regulatory T Cells in MS Patients (2013) (75)
- Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis (2014) (75)
- Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis. (2016) (74)
- Role of B Cells in Multiple Sclerosis and Related Disorders (2020) (73)
- Regulatory Functions of Natural Killer Cells in Multiple Sclerosis (2016) (72)
- Phenotypic and functional characterisation of CCR7+ and CCR7- CD4+ memory T cells homing to the joints in juvenile idiopathic arthritis (2005) (72)
- Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis (2005) (71)
- Pregnancy decision-making in women with multiple sclerosis treated with natalizumab (2018) (69)
- Stem cells in inflammatory demyelinating disorders: a dual role for immunosuppression and neuroprotection (2006) (67)
- An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients. (1998) (67)
- Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS study (2008) (66)
- Human Mesenchymal Stem Cells Impact Th17 and Th1 Responses Through a Prostaglandin E2 and Myeloid-Dependent Mechanism (2016) (65)
- Pregnancy decision-making in women with multiple sclerosis treated with natalizumab (2018) (64)
- The molecular signature of therapeutic mesenchymal stem cells exposes the architecture of the hematopoietic stem cell niche synapse (2007) (64)
- Blood-Brain Barrier Alterations in the Cerebral Cortex in Experimental Autoimmune Encephalomyelitis (2012) (63)
- Mesenchymal stem cells as treatment for MS – progress to date (2013) (62)
- B-cell differentiation in the CNS of patients with multiple sclerosis. (2005) (62)
- Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis. (2004) (60)
- The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction (2016) (60)
- Costs and quality of life of multiple sclerosis in Italy (2006) (58)
- Mesenchymal stem cells for the treatment of neurological diseases: Immunoregulation beyond neuroprotection. (2015) (58)
- Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis. (2001) (57)
- Regulation of human mesenchymal stem cell functions by an autocrine loop involving NAD+ release and P2Y11-mediated signaling. (2011) (56)
- Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer’s mice (2020) (56)
- Immunotherapy for neurological diseases. (2008) (55)
- Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration (2017) (54)
- X-Ray Phase Contrast Tomography Reveals Early Vascular Alterations and Neuronal Loss in a Multiple Sclerosis Model (2017) (53)
- Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial (2014) (51)
- Characterization of the TCRB chain repertoire in the New World monkey Callithrix jacchus. (1997) (51)
- Gabapentin is effective in treating nocturnal painful spasms in multiple sclerosis (2000) (50)
- Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors as therapeutics: rationales, controversies, clinical experience. (2013) (49)
- Patient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study (2012) (47)
- MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis (2019) (47)
- Role of miRNAs shuttled by mesenchymal stem cell-derived small extracellular vesicles in modulating neuroinflammation (2021) (47)
- Towards Clinical Application of Mesenchymal Stem Cells for Treatment of Neurological Diseases of the Central Nervous System (2013) (46)
- Exploring Alzheimer's disease mouse brain through X-ray phase contrast tomography: From the cell to the organ (2019) (46)
- Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study (2016) (45)
- Is there a role for mesenchymal stem cells in autoimmune diseases? (2008) (44)
- Recommendations for the management of urinary disorders in multiple sclerosis: a consensus of the Italian Multiple Sclerosis Study Group (2011) (44)
- Low intensity lympho-ablative regimen followed by autologous hematopoietic stem cell transplantation in severe forms of multiple sclerosis: A MRI-based clinical study (2015) (43)
- Immunological patterns identifying disease course and evolution in multiple sclerosis patients (2005) (43)
- Quantitative 3D investigation of Neuronal network in mouse spinal cord model (2017) (41)
- Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing–remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study) (2017) (40)
- Myelin/Oligodendrocyte Glycoprotein-Induced Autoimmune Encephalomyelitis in Common Marmosets: The Encephalitogenic T Cell Epitope pMOG24–36 Is Presented by a Monomorphic MHC Class II Molecule (2000) (39)
- Transport at basin scales: 2. Applications (2005) (39)
- Effect of radial shock wave therapy on pain and muscle hypertonia: a double-blind study in patients with multiple sclerosis (2015) (38)
- Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification (2012) (37)
- Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy (2021) (37)
- Quantitative Assessment of Finger Motor Impairment in Multiple Sclerosis (2013) (37)
- Reward responsiveness and fatigue in multiple sclerosis (2013) (37)
- Primary varicella zoster infection associated with fingolimod treatment (2011) (36)
- IFN‐&ggr; orchestrates mesenchymal stem cell plasticity through the signal transducer and activator of transcription 1 and 3 and mammalian target of rapamycin pathways (2017) (34)
- Cingulum bundle alterations underlie subjective fatigue in multiple sclerosis (2015) (33)
- Mechanisms of the adaptive immune response inside the central nervous system during inflammatory and autoimmune diseases. (2006) (33)
- Central and peripheral nervous system complications following allogeneic bone marrow transplantation (2001) (33)
- Teriflunomide treatment reduces B cells in patients with MS (2017) (32)
- Early switch to fingolimod may decrease the risk of disease recurrence after natalizumab interruption (2013) (32)
- Intrathecal Soluble HLA-E Correlates with Disease Activity in Patients with Multiple Sclerosis and may Cooperate with Soluble HLA-G in the Resolution of Neuroinflammation (2013) (32)
- Economic evaluation of treating clinically isolated syndrome and subsequent multiple sclerosis with interferon β-1b (2009) (32)
- Biological markers of the inflammatory phase of multiple sclerosis (2003) (31)
- IFNβ enhances mesenchymal stromal (Stem) cells immunomodulatory function through STAT1-3 activation and mTOR-associated promotion of glucose metabolism (2019) (31)
- Relapses after treatment with rituximab in a patient with multiple sclerosis and anti myelin-associated glycoprotein polyneuropathy. (2007) (31)
- Neurological Complications and Noninvasive Multimodal Neuromonitoring in Critically Ill Mechanically Ventilated COVID-19 Patients (2020) (30)
- Association of melanoma and natalizumab therapy in the Italian MS population: a second case report (2011) (30)
- Treatment of multiple sclerosis with rituximab: A multicentric Italian–Swiss experience (2019) (30)
- Dramatic rebounds of MS during pregnancy following fingolimod withdrawal (2017) (30)
- Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy (2016) (28)
- Systemic Administration of Mesenchymal Stem Cells Increases Neuron Survival after Global Cerebral Ischemia In Vivo (2VO) (2010) (28)
- Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice (2019) (27)
- Heterogeneity at the HLA-DRB 1 locus and risk for multiple sclerosis (2006) (27)
- A RCT Comparing Specific Intensive Cognitive Training to Aspecific Psychological Intervention in RRMS: The SMICT Study (2015) (27)
- Autologous Stem Cell Transplantation for Severe Autoimmune Diseases (2007) (26)
- Sirt6 regulates dendritic cell differentiation, maturation, and function (2016) (26)
- Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial (2021) (26)
- Mesenchymal stem cells for multiple sclerosis: does neural differentiation really matter? (2011) (26)
- Overexpression of sphingosine-1-phosphate receptors on reactive astrocytes drives neuropathology of multiple sclerosis rebound after fingolimod discontinuation (2018) (26)
- COVID-19 in patients with multiple sclerosis undergoing disease-modifying treatments (2020) (26)
- COVID-19-related and not related Guillain-Barré syndromes share the same management pitfalls during lock down: The experience of Liguria region in Italy (2020) (25)
- Tailoring B cell depletion therapy in MS according to memory B cell monitoring (2020) (25)
- Th17 Cells in Multiple Sclerosis Express Higher Levels of JAK2, Which Increases Their Surface Expression of IFN-γR2 (2012) (25)
- CCL5-glutamate interaction in central nervous system: Early and acute presynaptic defects in EAE mice (2013) (24)
- Fulminant Hepatitis Associated With Echovirus 25 During Treatment With Ocrelizumab for Multiple Sclerosis. (2019) (24)
- Retinal nerve fibre layer measurements and optic nerve head analysis in multiple sclerosis patients (2009) (23)
- Human mesenchymal stem cells target adhesion molecules and receptors involved in T cell extravasation (2015) (23)
- Long-term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis (2021) (23)
- NG2, a common denominator for neuroinflammation, blood–brain barrier alteration, and oligodendrocyte precursor response in EAE, plays a role in dendritic cell activation (2016) (22)
- Conventional Perimetry, Short-Wavelength Automated Perimetry, Frequency-Doubling Technology, and Visual Evoked Potentials in the Assessment of Patients with Multiple Sclerosis (2005) (22)
- Sirt6 inhibition delays the onset of experimental autoimmune encephalomyelitis by reducing dendritic cell migration (2020) (21)
- Signals of pseudo-starvation unveil the amino acid transporter SLC7A11 as key determinant in the control of Treg cell proliferative potential. (2021) (21)
- Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS Population (2020) (21)
- Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis (2005) (21)
- Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders. (2019) (20)
- Antibodies against Epstein–Barr virus and herpesvirus type 6 are associated with the early phases of Multiple Sclerosis (2007) (20)
- Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS (2019) (20)
- CD56bright Natural Killer Cells: A Possible Biomarker of Different Treatments in Multiple Sclerosis (2020) (20)
- A randomized, placebo-controlled, phase 2 trial of laquinimod in primary progressive multiple sclerosis (2020) (19)
- Contact with the bone marrow microenvironment readdresses the fate of transplanted hematopoietic stem cells. (2010) (19)
- Hereditary motor and sensory neuropathy with myelin outfolding: Clinical, genetic and neuropathological study of three cases (1994) (18)
- Tocilizumab in MOG-antibody spectrum disorder: a case report. (2019) (17)
- Anti-glutamic acid decarboxylase limbic encephalitis without epilepsy evolving into dementia with cerebellar ataxia. (2012) (17)
- Mesenchymal stem cells exert a remarkable regenerative effect requiring minimal CNS integration Commentary on: “Mesenchymal stem cells protect CNS neurons against glutamate excitotoxicity by inhibiting glutamate receptor expression and function” by Voulgari-Kokota et al. (2013) (17)
- Stem cell transplantation in multiple sclerosis (2010) (17)
- Selective impairments of motor sequence learning in multiple sclerosis patients with minimal disability (2014) (17)
- EAE in the common marmoset Callithrix jacchus. (2003) (16)
- COVID-19 Vaccination in Fragile Patients: Current Evidence and an Harmonized Transdisease Trial (2021) (16)
- Autoantibody Diagnostics in Neuroimmunology: Experience From the 2018 Italian Neuroimmunology Association External Quality Assessment Program (2020) (16)
- Two Years Follow up of Domain Specific Cognitive Training in Relapsing Remitting Multiple Sclerosis: A Randomized Clinical Trial (2016) (16)
- Induction of experimental autoimmune encephalomyelitis in rats and immune response to myelin basic protein in lipid-bound form (1993) (15)
- Autologous haematopoietic stem-cell transplantation in multiple sclerosis: benefits and risks (2009) (15)
- Neuroinflammation induces synaptic scaling through IL-1β-mediated activation of the transcriptional repressor REST/NRSF (2021) (15)
- Acute desipramine restores presynaptic cortical defects in murine experimental autoimmune encephalomyelitis by suppressing central CCL5 overproduction (2014) (15)
- Restricted immune responses lead to CNS demyelination and axonal damage (2000) (15)
- Characterization of mouse spinal cord vascular network by means of synchrotron radiation X-ray phase contrast tomography. (2016) (15)
- Neurorepair with mesenchymal stem cells: hope or hype? (2012) (14)
- Different MRI patterns in MS worsening after stopping fingolimod (2019) (14)
- Investigation of paroxysmal dystonia in a patient with multiple sclerosis: A transcranial magnetic stimulation study (2008) (14)
- Pediatric optic neuritis and anti MOG antibodies: a cohort of Italian patients. (2019) (13)
- Aggressive multiple sclerosis: a single‐centre, real‐world treatment experience with autologous haematopoietic stem cell transplantation and alemtuzumab (2020) (13)
- Ecological impact of isolated cognitive relapses in MS (2018) (13)
- Immuno-therapeutic potential of haematopoietic and mesenchymal stem cell transplantation in MS. (2010) (12)
- Alterations of glutamate release in the spinal cord of mice with experimental autoimmune encephalomyelitis (2010) (12)
- Myelin basic protein intramolecular spreading without disease progression in a patient with multiple sclerosis (2000) (12)
- Impact of treatment on cellular immunophenotype in MS (2020) (11)
- Stem cells for multiple sclerosis: promises and reality. (2007) (11)
- ARPEGGIO: A randomized, placebo-controlled study to evaluate oral laquinimod in patients with primary progressive multiple sclerosis (PPMS) (P7.210) (2015) (10)
- Clinical baseline factors predict response to natalizumab: their usefulness in patient selection (2014) (10)
- Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis (2021) (10)
- Humoral and T-cell immune response after three doses of mRNA SARS-CoV-2 vaccines in fragile patients: the Italian VAX4FRAIL study (2022) (10)
- Neurological manifestations in autoinflammatory diseases. (2018) (10)
- Neuroaxonal Degeneration in Patients With Multiple Sclerosis: An Optical Coherence Tomography and in Vivo Corneal Confocal Microscopy Study. (2020) (9)
- Mesenchymal stromal cells and immunity: Introductory overview. (2015) (9)
- Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS (2020) (9)
- Hydroxycarboxylic Acid Receptor 2, a Pleiotropically Linked Receptor for the Multiple Sclerosis Drug, Monomethyl Fumarate. Possible Implications for the Inflammatory Response (2021) (9)
- High or increasing serum NfL is predictive of impending multiple sclerosis relapses. (2022) (8)
- Adult stem cells for spinal cord injury: what types and how do they work? (2008) (8)
- Differential display analysis of murine encephalitogenic mRNA. (1998) (8)
- Composite MRI measures and short-term disability in patients with clinically isolated syndrome suggestive of MS (2018) (8)
- Different Susceptibility of T and B Cells to Cladribine Depends On Their Levels of Deoxycytidine Kinase Activity Linked to Activation Status (2021) (8)
- Iconographies supplémentaires de l'article : IFN-? orchestrates mesenchymal stem cell plasticity through the signal transducer and activator of transcription 1 and 3 and mammalian target of rapamycin pathways (2016) (8)
- COVID-19 vaccine-related Guillain-Barré syndrome in the Liguria region of Italy: A multicenter case series (2022) (8)
- In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanoma. (2017) (8)
- Vaccination with amyloid-b peptide induces autoimmune encephalomyelitis in C 57 / BL 6 mice (8)
- CSF oligoclonal bands and normal appearing white matter periventricular damage in patients with clinically isolated syndrome suggestive of MS. (2019) (7)
- Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis (2022) (7)
- Characterization of the response to myelin basic protein in a non human primate model for multiple sclerosis (2001) (7)
- MiR‐142‐3p regulates synaptopathy‐driven disease progression in multiple sclerosis (2021) (7)
- Serum sickness (Like Reaction) in a patient treated with alemtuzumab for multiple sclerosis: A case report. (2018) (6)
- Multiple sclerosis and non‐communicating syringomyelia: a casual association or linked diseases? (1999) (6)
- Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study (2022) (6)
- An Early Increase of Blood Leukocyte Subsets in Aneurysmal Subarachnoid Hemorrhage Is Predictive of Vasospasm (2020) (6)
- Dynamics of the reactivity to MBP in multiple sclerosis. (2000) (6)
- Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study (2022) (6)
- Mesenchymal stem cells instruct a beneficial phenotype in reactive astrocytes (2020) (6)
- Neurological long-COVID in the outpatient clinic: Two subtypes, two courses (2022) (6)
- Intractable myoclonus associated with anti-GluR3 antibodies after allogeneic bone marrow transplantation. (2006) (6)
- Corneal epithelial dendritic cells in patients with multiple sclerosis: An in vivo confocal microscopy study (2020) (5)
- Mesenchymal Stem Cells for the Treatment of Multiple Sclerosis (2013) (5)
- New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab (2020) (5)
- ARPEGGIO: a placebo-controlled trial of oral laquinimod in primary progressive multiple sclerosis (S8.003) (2018) (5)
- Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients (2022) (5)
- X-ray Phase Contrast Tomography Serves Preclinical Investigation of Neurodegenerative Diseases (2020) (5)
- Therapeutic recommendations and seasonal influenza vaccine for multiple sclerosis patients in treatment with ocrelizumab: an expert consensus (2021) (5)
- Neuroprotective Potential of Dendritic Cells and Sirtuins in Multiple Sclerosis (2022) (5)
- Microglia-derived CCL2 has a prime role in neocortex neuroinflammation (2022) (5)
- Intravenous immunoglobulin, plasmalymphocytapheresis and azathioprine in chronic progressive multiple sclerosis (1994) (5)
- Ghost spasticity in multiple sclerosis. (2020) (4)
- A Single Nucleotide ADA Genetic Variant Is Associated to Central Inflammation and Clinical Presentation in MS: Implications for Cladribine Treatment (2020) (4)
- Animal Models of Demyelination of the Central Nervous System (1999) (4)
- A case of thyroiditis during natalizumab therapy for multiple sclerosis (2011) (4)
- Pregnancy and Fetal Outcomes after In Utero Exposure to Natalizumab in Patients with Multiple Sclerosis: A Prospective, Nation-Wide, Controlled Study (S24.006) (2016) (4)
- Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study (2022) (4)
- Monomethyl fumarate inhibits the NFkB pathway and pro-inflammatory cytokine expression in microglia through HCA2 signaling via the AMPK/Sirt axis (2014) (3)
- encephalomyelitis inducing T-cell anergy Mesenchymal stem cells ameliorate experimental autoimmune (2012) (3)
- Relationship Between Retinal Layers Thickness and Disability Worsening in Relapsing-Remitting and Progressive Multiple Sclerosis. (2020) (3)
- Effect of vitamin D supplementation on N‐glycan branching and cellular immunophenotypes in MS (2020) (3)
- Pregnancy does not prevent disease re-activation after natalizumab suspension in patients with multiple sclerosis (2015) (3)
- Degree of microstructural changes within T1-SE versus T1-GE hypointense lesions in multiple sclerosis: relevance for the definition of “black holes” (2020) (3)
- 18F-Fluorodeoxyglucose Positron Emission Tomography Tracks the Heterogeneous Brain Susceptibility to the Hyperglycemia-Related Redox Stress (2020) (3)
- Microvascular pericytes involvement in experimental autoimmune encephalomyelitis (2011) (2)
- CD19+ B cell values predict the increase of anti-SARS CoV2 antibodies in fingolimod-treated and COVID-19-vaccinated patients with multiple sclerosis (2022) (2)
- A major influence of the T cell receptor repertoire as compared to antigen processing–presentation in the selection of myelin basic protein epitopes in multiple sclerosis (1999) (2)
- A bridge between evidence-based laboratory diagnostics and research in neuroimmunology: why standardizations and guidelines matter (2017) (2)
- Micro-RNAs Shuttled by Extracellular Vesicles Secreted from Mesenchymal Stem Cells Dampen Astrocyte Pathological Activation and Support Neuroprotection in In-Vitro Models of ALS (2022) (2)
- Brain disconnectome mapping and serum neurofilament light levels in multiple sclerosis (2021) (2)
- Effectiveness of Time Domain and Spectral Domain Optical CoherenceTomograph to Evaluate Eyes with And Without Optic Neuritis in MultipleSclerosi Patients (2016) (2)
- Effects of aging on finger movements in multiple sclerosis. (2020) (2)
- Exosome-shuttled miRNAs contribute to the modulation of the neuroinflammatory microglia phenotype by mesenchymal stem cells. Implication for amyotrophic lateral sclerosis (2019) (2)
- Safety of third dose of COVID-19 vaccination in frail patients: Results from the prospective Italian VAX4FRAIL study (2022) (2)
- Can we kill an extra bird with the same stone? (2011) (1)
- Impact of Natural Killer (NK) Cells on Immune Reconstitution, and Their Potential as a Biomarker of Disease Activity, in Alemtuzumab-Treated Patients with Relapsing Remitting Multiple Sclerosis: An Observational Study (2021) (1)
- Brain disconnectome mapping derived from white matter lesions and serum neurofilament light levels in multiple sclerosis: A longitudinal multicenter study (2022) (1)
- Retinal Nerve Fiber Layer Measurements and Optic Nerve Head Analysis in Multiple Sclerosis Patients (2007) (1)
- Immunolocalization of CCL2-expressing cells in EAE and EAE-MSC cerebral cortex (2015) (1)
- Predicting multiple sclerosis: a large international multicentre study (2015) (1)
- Human Bone Marrow Mesenchymal Stem Cells Support Polyclonal Stimulation of Human B Cells (2007) (1)
- Phenotypic and functional characterisation of CCR 7 + and CCR 7-CD 4 + memory T cells homing to the joints in juvenile idiopathic arthritis (2015) (1)
- [REST and CREST syndromes: etiopathogenetic, clinical and therapeutic aspects of partial forms of progressive systemic sclerosis]. (1984) (1)
- Prevention of EAE in non-human primates by a type IV phosphodiesterase inhibitor that suppresses tumor necrosis factor (1994) (1)
- Mult Scler Antonio Uccelli , Alice Laroni and Mark S Freedman progress to date − Mesenchymal stem cells as treatment for MS (2013) (1)
- Bone Marrow Transfer in Relapsing-Remitting EAE Ameliorates Disease at First Remission, with No Synergistic Effect upon Co-Transplantation with Mesenchymal Stem Cells (2021) (1)
- Choroidal Thickness in Multiple Sclerosis: An Optical Coherence Tomography Study (2022) (1)
- Assessing upper limb function in multiple sclerosis using an engineered glove (2020) (1)
- Disease re-activation during pregnancy after natalizumab suspension in patients with multiple sclerosis (2015) (1)
- Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters (2022) (1)
- Experimental autoimmune encephalomyelitis in the common marmoset Callithrix jacchus (1999) (1)
- The role of disconnection in explaining disability in multiple sclerosis (2022) (1)
- Neuropathological Advances in Multiple Sclerosis (2007) (1)
- Fingolimod Modulates Peripheral Effector and Regulatory T Cells in MS Patients (2013) (0)
- Sustained disease remission in multiple sclerosis after autologous haematopoietic stem cell transplantation. The Italian experience (2017) (0)
- OR.82. Mesenchymal Stem Cells Treat CNS Autoimmunity Through a Dual Effect On Inflammation and Tissue Damage (2006) (0)
- X-ray phase contrast tomography reveals early vascular alterations and neuronal loss in neurological disorders (2018) (0)
- IFNβ enhances mesenchymal stromal (Stem) cells immunomodulatory function through STAT1-3 activation and mTOR-associated promotion of glucose metabolism (2019) (0)
- The state of MS: treatment goals and challenges (2015) (0)
- Multiscale networks in multiple sclerosis (2023) (0)
- Cell therapy (SY5-1) Chairpersons: Masaru Taniguchi, Jacques Banchereau (2010) (0)
- Safety and tolerability of fingolimod in relapsing- remitting multiple sclerosis: resuls from a large open-label clinical trials. (2014) (0)
- Unraveling the regulatory role of NK cells on T-cell effector functions: Implications for CNS autoimmunity (2014) (0)
- Dissection of the distinct susceptibility of hematopoietic precursors and immune cells to cladribine (2018) (0)
- Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification (2012) (0)
- Possible role of miRNAs in the modulation of neuroinflammation by mesenchymal stem cells (2014) (0)
- Circulating Lymphocyte Subsets after Total Lymphoid Irradiation in Chronic Progressive Multiple Sclerosis (1993) (0)
- MBP specific T-cell clones share few conserved CDR3 motifs in primate EAE (1998) (0)
- Their Surface Expression of IFN- Higher Levels of JAK2, Which Increases Th17 Cells in Multiple Sclerosis Express (2012) (0)
- Evaluation of ganglion cell complex after optic neuritis by OCT. (2015) (0)
- T-helper 17 lymphocytes during MS relapses: antigen specifity and cytokine production. A multicentre longitudinal sudy (2009) (0)
- Intravenous immunoglobulin bridging to rituximab in NMDAR encephalitis patients non-responders to first-line treatments (2022) (0)
- Therapy with mesenchymal stem cell transplantation in multiple sclerosis is ready for prime time: No (2022) (0)
- Towards Clinical Application of Mesenchymal Stem Cells for Treatment of Neurological Diseases of the Central Nervous System (2013) (0)
- FP17-TU-06 Th17, an effector T lymphocyte subset associated with multiple sclerosis (MS) relapses: antigen specificity, cytokine production, and sensitivity to interferon (IFN)-β (2009) (0)
- Isolated cognitive relapses and long-term cognitive decline in multiple sclerosis (P5.195) (2015) (0)
- Erratum: Choroidal Thickness in Multiple Sclerosis: An Optical Coherence Tomography Study (2022) (0)
- Systemic Inflammatory Response in Spontaneous Subarachnoid Hemorrhage from Aneurysmal Rupture versus Subarachnoid Hemorrhage of Unknown Origin (2022) (0)
- IL- 17 and IL-22 producing increased in multiple sclerosis relapses are MBP-specific. A multi-centre longitudinal study (2009) (0)
- Enrichment analysis of GWAS data in autoimmunity delineates the multiple sclerosis-Epstein Barr virus association (2021) (0)
- R2 γ Expression of IFN- Levels of JAK2, Which Increases Their Surface Th17 Cells in Multiple Sclerosis Express Higher (2012) (0)
- MESENCHYMAL STEM CELL-DERIVED SECRETOME FULLY REPLICATE CELL-MEDIATED NEURO-REPARATIVE ACTIVITIES IN THE APP/PS1 MOUSE MODEL OF ALZHEIMER’S DISEASE (2019) (0)
- Neuronal Activity in Primate Striatum Influence of Reward Expectation on Behavior-Related (2015) (0)
- Rainfall Spatial Patterns and Catchment-Scale Geomorphic Hydrologic Response (2005) (0)
- Mesenchymal Stem/Stromal Cells for Multiple Sclerosis and Other Neurological Diseases (2021) (0)
- Tight junction protein changes in experimental autoimmune encephalomyelitis models (2011) (0)
- MSJ872889_supplemental_table – Supplemental material for Treatment of multiple sclerosis with rituximab: A multicentric Italian–Swiss experience (2019) (0)
- Human mesenchymal stem cells target adhesion molecules and receptors involved in T cell extravasation (2015) (0)
- Autologous hematopoietic stem cell transplantation versus alemtuzumab in aggressive MS: a retrospective real-word study (4096) (2020) (0)
- Aging with multiple sclerosis: Clinical characterization of an elderly population, a cross-sectional study. (2022) (0)
- MESEMS: a randomized, double blind placebo-controlled cross-over study to evaluate safety and efficacy of intravenous administration of autologous mesenchymal stem cells in patients with multiple sclerosis (2015) (0)
- Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Commentary (2005) (0)
- Depletion of the intracellular coenzyme NAD plus in activated T-cells ameliorates experimental autoimmune encephalomyelitis (2009) (0)
- The therapeutic effect of mesenchymal stem cell transplantation in experimental autoimmune encephalomyelitis is mediated by peripheral and central mechanisms (2012) (0)
- Choroidal thickness changes in patients with hemodynamically significant carotid stenosis (2016) (0)
- Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer’s mice (2020) (0)
- Microglia-derived CCL2 has a prime role in neocortex neuroinflammation (2022) (0)
- Vaccination Opportunities in Multiple Sclerosis Patients Treated with Cladribine Tablets (2021) (0)
- TCR repertoire in non-human primates: Diversity of T-cell response against MBP (1995) (0)
- Impact of Soil Depths on the Catchment-Scale Geomorphic Hydrologic Response (2005) (0)
- Epithelial cell Neuron Bone marrowBone MSC Self-renewal Ectoderm Fat cell Bone cell Muscle cell Gut epithelial cell Mesoderm Cartilage cell (0)
- 10 Mesenchymal stem cells as a strategy for the treatment of multiple sclerosis and other diseases of the central nervous system (2013) (0)
- Antibodies mediate cerebral graft versus host disease (1998) (0)
- X-Ray Phase Contrast Tomography Reveals Early Vascular Alterations and Neuronal Loss in a Multiple Sclerosis Model (2017) (0)
- Do NK cells play a role in the possible association between natalizumab treatment and the development of melanoma? (2014) (0)
- Hereditary motor and sensory neuropathy with myelin outfolding: Clinical, genetic and neuropathological study of three cases J. neurol. sci., 122(1994) 20–27 (1994) (0)
- Role of miRNAs shuttled by mesenchymal stem cell-derived small extracellular vesicles in modulating neuroinflammation (2021) (0)
- Bone marrow mesenchymal stem cell-derived secreted factors promote the proliferation of adult subventricular zone-neural stem cells and foster their stemness in vitro under pathogenic conditions (2014) (0)
- Mesenchymal stem cells modulate microglia activation via exosome-shuttled microRNA (2017) (0)
- Analysis of the interferon gamma modulated pathways related to the therapeutic plasticity of bone marrow-derived mesenchymal stem cells through a SILAC-based proteomic approach (2014) (0)
- Corrigendum: X-ray Phase Contrast Tomography Serves Preclinical Investigation of Neurodegenerative Diseases (2021) (0)
- Abstracts from the International Symposium “Signal Transduction at the Blood–Brain Barriers” 2022 (2023) (0)
- Intrathecal Soluble HLA-E Correlates with Disease Activity in Patients with Multiple Sclerosis and may Cooperate with Soluble HLA-G in the Resolution of Neuroinflammation (2013) (0)
- Lack of NG2 expression on immune cells and oligodendrocytes progenitor cells modulates EAE phenotype (2014) (0)
- NG2+ Oligodendrocyte Precursor Cells (OPCs) take part in neurovascular unit remodelling during EAE (2013) (0)
- The State of Multiple Sclerosis Survey: Relationship of Expectations, Decision-Making, Communication, and Satisfaction with Treatment (P3.235) (2015) (0)
- BBB-endothelial tight junction response to mesenchymal stem cells in a model of MOG EAE (2015) (0)
- Sirt6 inhibition delays the onset of experimental autoimmune encephalomyelitis by reducing dendritic cell migration (2020) (0)
- Restricted T-cell response to MBP over time in MS patients (1995) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Antonio Uccelli?
Antonio Uccelli is affiliated with the following schools:
